WHO and MPP announce agreement with NIH for COVID-19 health technologies

Via Peters

WHO’s COVID-19 Technology Access Pool (C-TAP) and the Medicines Patent Pool (MPP) today finalized a licensing agreement with the United States National Institutes of Health (NIH) for the development of several innovative therapeutics, early-stage vaccines and diagnostic tools for COVID-19. The licenses, which are transparent, global and non-exclusive, will allow […]